H.R. 7384 · 118th Congress
Creating Hope Reauthorization Act of 2024
- Stage
- In committee
- Sponsor
- Michael McCaul
- Introduced
- 2024-02-15
- Latest action
- 2024-02-16 · Referred to the Subcommittee on Health.
Summary
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)